Garsuta, Jennifer T.

HRN: 29-27-17  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/05/2026
07/12/2026
IV
500mg
Q8
T/c Acute Appendicitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: Compliant To Guidelines